Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin in Severe Alcoholic Hepatitis
NCT02326103Phase 1Completed
- Sponsor
- University of Helsinki
- Start
- Apr 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ciprofloxacin in alcoholic hepatitis (AH), sponsored by University of Helsinki. Primary endpoint: Death at 12 months. Started Apr 2015; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT02326103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02326103.